Arabic Arabic English English French French German German
dark

Recordati Rare Diseases Announces William Ludlam, MD, PhD, As New Chief Medical Officer and Vice President – Clinical Development

Recordati Rare Diseases Inc. is pleased to welcome William Ludlam, MD, PhD, in the role of Chief Medical Officer and Vice President – Clinical Development. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

MassBio Industry Snapshot Predicts 40,000 New Biopharma Jobs Over the Next 10 Years

Next Post

Rapid Dose Therapeutics Reports Fiscal Year 2021 Financial Results

Related Posts
Total
0
Share